Study to Determine the Efficacy and Safety of TG-C in Subjects With Kellgren/Lawrence Grade 2 or 3 OA of the Knee
NCT03291470
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
531
Enrollment
INDUSTRY
Sponsor class
Conditions
Degenerative Osteoarthritis
Interventions
BIOLOGICAL:
TG-C
BIOLOGICAL:
Placebo Control
Sponsor
Kolon TissueGene, Inc.